The most frequently reported reactions include: Redness (erythema) at the application site Itching or a tingling/stinging sensation , especially on freshly exfoliated or compromised skin Dryness or mild flaking , sometimes related to the overall formulation rather than the peptide itself Temporary irritation when combined with strong actives These reactions typically resolve on their own or after reducing frequency of use
10.1093/stmcls/sxad010 Summary Keywords diabetic kidney disease (DKD), sodium-glucose co-transporter 2 inhibitors (SGLT2i), finerenone, gut-kidney axis, cardiorenal protection Citation Zhang H, Wang K, Zhao H, Qin B, Cai X, Wu M, Li J and Wang J (2025) Diabetic kidney disease: from pathogenesis to multimodal therapycurrent evidence and future directions
[15] GHK-Cu has been shown to produce anti-inflammatory effects and stimulate release of growth factors such as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2)
Enriched with potent botanical extracts that help to reduce pigmentation while providing comprehensive protection against tanning, environmental aggressors, and DNA damage